Trials / Completed
CompletedNCT03199118
Use of Platelet Rich Fibrin in Addition to CAF and SCTG for Treatment of Gingival Recession
The Use of Coronally Advanced Flap and Subepithelial Connective Tissue Graft With or Without Platelet Rich Fibrin in the Treatment of Miller Class I or II Gingival Recession: a Randomized Clinical Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 28 (actual)
- Sponsor
- Cairo University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
This research will be conducted in an attempt to achieve complete root coverage with physiologic probing depth and a harmonious view with the adjacent tissues using Platelet rich fibrin in conjunction with Coronally advanced flap and subepithelial connective tissue graft.
Detailed description
The study population will be divided into 2 groups: Group 1: Patients suffering from Miller class I or II gingival recession will be treated with a coronally advanced flap in conjunction with a sub-epithelial connective tissue graft. The patients should be non-smoker, medically free and above 18 years Group 2: Patients suffering from Miller class I or II gingival recession will be treated with a coronally advanced flap in conjunction with a sub-epithelial connective tissue graft and platelet rich fibrin. the patients should meet the same inclusion criteria mentionned above.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | CAF +SCTG | the use of coronally advanced flap (CAF) with sub-epithelial connective tissue graft (SCTG) from the palate to cover gingival recession |
| OTHER | platelet rich fibrin | in addition to coronally advanced flap and sub-epithelial connective tissue graft, PRF is also used in the surgical procedure to cover gingival recession |
Timeline
- Start date
- 2018-01-01
- Primary completion
- 2019-12-31
- Completion
- 2019-12-31
- First posted
- 2017-06-26
- Last updated
- 2021-03-22
- Results posted
- 2021-03-22
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT03199118. Inclusion in this directory is not an endorsement.